| For: | Lin ZM, Gao HY, Shi SH, Li YT. Mizagliflozin ameliorates diabetes induced kidney injury by inhibitor inhibit inflammation and oxidative stress. World J Diabetes 2025; 16(1): 92711 [PMID: 39817219 DOI: 10.4239/wjd.v16.i1.92711] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i1/92711.htm |
| Number | Citing Articles |
| 1 |
Anna Berecka-Rycerz, Anna Gumieniczek, Julia Skroban, Katarzyna Wicha-Komsta. Beyond SGLT2: Exploring the Therapeutic Potential of Lesser-Known SGLT Isoform Inhibitors. Applied Sciences 2025; 15(21): 11603 doi: 10.3390/app152111603
|
| 2 |
Meng Gao, Meng-Ting Dai, Guo-Hua Gong. Dysfunctional glucose metabolism triggers oxidative stress to induce kidney injury in diabetes. World Journal of Diabetes 2025; 16(4): 102554 doi: 10.4239/wjd.v16.i4.102554
|
